BIO-key International to Join H.C. Wainwright Conference
BIO-key International to Join H.C. Wainwright Conference
BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software, will participate at H.C. Wainwright’s 26th Annual Hybrid Global Investment Conference. This event is scheduled for September 9th and 10th.
CEO Availability for Meetings
BIO-key’s CEO Mike DePasquale will be available for virtual meetings on Monday and Tuesday, September 9th and 10th. Interested parties can coordinate with their H.C. Wainwright representative or directly contact the company's representatives to schedule a meeting.
Conference Presentation Details
BIO-key’s conference presentation will be accessible to registered attendees starting on the morning of September 9th. This is an opportunity for those interested in exploring the latest advancements in IAM technology to gain insights directly from the company.
About BIO-key International, Inc.
BIO-key is at the forefront of revolutionizing authentication and cybersecurity with its biometric-centric, multi-factor identity and access management (IAM) software. Currently, the company secures access for over 40 million users worldwide. Customers can select from a range of authentication methods, including phoneless, tokenless, and passwordless biometric solutions.
Cloud and On-Premise Solutions
With solutions that are both cloud-hosted and on-premise, BIO-key’s PortalGuard IAM system is designed to be cost-effective and user-friendly. This allows for easy deployment and secure access to computers, information, applications, and high-value transactions, catering to diverse business needs.
Engage with BIO-key International
For more information, BIO-key encourages engagement through various corporate social platforms. Users can find them on major platforms for updates and insights about their software solutions and company news.
Investor Relations Information
For investor inquiries, William Jones and David Collins from Catalyst IR can be contacted. They are available via email or phone to discuss any potential investor concerns or details related to the company's performance and future outlook.
Frequently Asked Questions
What is BIO-key International known for?
BIO-key International specializes in Identity and Access Management (IAM) software, focusing on biometric authentication technologies.
When will BIO-key present at the conference?
BIO-key will present at the H.C. Wainwright conference on September 9th and 10th.
How can I schedule a meeting with BIO-key's CEO?
Meetings with the CEO can be scheduled by contacting H.C. Wainwright representatives or directly reaching out to BIO-key representatives.
What solutions does BIO-key offer?
BIO-key offers a variety of IAM solutions, including passwordless, phoneless, and tokenless authentication methods that are easy to deploy and maintain.
Who can I contact for investor relations?
Investor contacts for BIO-key are William Jones and David Collins from Catalyst IR, reachable by email or phone.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.